{
  "docId": "019de076-aef8-73ee-832d-fdb26bc98608",
  "docSlug": "c95c061ca7ee3d0fc69daa81d5a345ff",
  "documentTitle": "Legend Biotech | Investor Presentation Deck | 14 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 14,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The chart highlights Carvykti's superior growth curve in its first six quarters compared to the peer set.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-aef8-73ee-832d-fdb26bc98608/5",
  "deckHref": "/decks/019de076-aef8-73ee-832d-fdb26bc98608",
  "deckJsonHref": "/decks/019de076-aef8-73ee-832d-fdb26bc98608.json",
  "deckAnchorHref": "/decks/019de076-aef8-73ee-832d-fdb26bc98608#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.94,
        "x": 0.03,
        "y": 0.0034
      },
      "kind": "chart",
      "text": "WORLDWIDE SALES OF CAR-T THERAPIES, BY QUARTER OF LAUNCH (IN $MM)",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a909178-8d9c-4b01-8e57-0414f3272209",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.3,
        "x": 0.56,
        "y": 0.0016
      },
      "kind": "paragraph",
      "text": "FIRST SIX QUARTERS OUTPERFORMING HISTORICAL CAR-T LAUNCHES",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8404f10c-ca55-42a3-9e91-dcfc53a98944",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.3,
        "x": 0.12,
        "y": 0.0016
      },
      "kind": "paragraph",
      "text": "CARVYKTI® - INDUSTRY LEADING EARLY LAUNCH PERFORMANCE",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e94087ac-7aac-4939-a0a9-fac0dc11e7a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.17,
        "x": 0.03,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Data Source: Companies' public filings.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fcbb8d3c-11a8-487b-9995-9f74e56ea77b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.58,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "A New Standard for CAR-T Launches",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4b1cad6-e786-42a8-967b-e2a4fce3804d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "568a2b67-6130-4579-8878-4234ae16919f",
      "evidence": "Comparing performance of multiple products over time",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "b7cf07ac-ff36-4994-b431-8a0e0287d1f3",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The deck presents market penetration, geographic expansion, and population in earlier lines of treatment as significant growth drivers.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d901a32e-9a4f-48f4-ab6e-1652e6d9562f",
      "evidence": "The deck highlights the potential consequences of not adopting Legend Biotech's solutions.",
      "position": 0,
      "objective": "Emphasize the importance of early adoption of Legend Biotech's cell therapy solutions.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}